Drug targeting system, method of its preparation and its use

Details Drug targeting system, method of its preparation and its use Drug targeting system, method of its preparation and its use

2006-04-11

2006-04-11

Hartley, Michael (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S501000

Reexamination Certificate

active

07025991

ABSTRACT:
A composition and method of fabrication are presented with which nanoparticles may be used as a tool to deliver drugs to a specific target within or on a mammalian body. Specifically, by using stabilizers other than Dextran 70.000 during the polymerization process, according to the present invention, surfactants, which were deemed necessary coating material in the prior art, are no longer required. This is a significant simplification of the fabrication procedure. Many substances are useful as stabilizers, but the preferred stabilizers comprise Dextran 12.000 or polysorbate 85. In the present invention a drug is either incorporated into or adsorbed onto the stabilized nanoparticles. This drug
anoparticle complex is then administered to the organism on any route such as by oral application, injection or inhalation, whereupon the drug exerts its effect at the desired site of pharmacological action. In a novel medical treatment process, the drug
anoparticle complex may be administered preferably either by intravenous injection or by oral application. The resulting drug action, which does not occur or which occurs only to an insufficient extent when the drug is administered alone, shows that when linked to said nanoparticles drugs can reach a specific target within or on the mammalian body. The usefulness of the present invention as a universal approach to deliver any drug or diagnostic agent to a specific target within or on the mammalian body was demonstrated by experiments showing an unexpected transfer of the drug across the blood brain barrier.

REFERENCES:
patent: 5133908 (1992-07-01), Stainmesse et al.
patent: 5759580 (1998-06-01), Jans et al.
patent: 5837221 (1998-11-01), Bernstein et al.
patent: 6117454 (2000-09-01), Kreuter et al.
patent: 197 45 950 (1999-04-01), None
patent: 330180 (1989-08-01), None
patent: 486959 (1992-05-01), None
patent: 261 2400 (1988-09-01), None
patent: 94/15590 (1994-07-01), None
patent: 95/22963 (1995-08-01), None
patent: WO 98/56361 (1998-12-01), None
patent: WO 00/74658 (2000-12-01), None
Beck P. et al., Influence of polybutylcyanoacrylate nanoparticles . . . , J. Microencapslulation, vol. 10, No. 1, pp. 101-112, 1993.
R. Reszka, et al., Journal of Pharmacology and Experimental Therapeutics, vol. 280, No. 1, pp. 232-237, “Body Distribution of Free Liposomal and Nanoparticle-Associated Mitoxantrone in B16-Melanoma-Bearing Mice”, 1997. XP-002129865.
P. Couvreur, et al., Journal of Pharmaceutical Sciences, vol. 71, No. 7, pp. 790-7925, “Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles”, Jul. 1982. 1XP-000783921.

Affiliated with

Also associated with

Rating

Drug targeting system, method of its preparation and its use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug targeting system, method of its preparation and its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug targeting system, method of its preparation and its use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3537355